Tideglusib protects neural stem cells against NMDA receptor overactivation-Reference-Cited by-同舟云学术

Tideglusib protects neural stem cells against NMDA receptor overactivation

Published:2015-10 Issue:5 Volume:67 Page:823-831
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Armagan Güliz,Keser Ayşegül,Atalayın Çiğdem,Dagcı Taner

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Oxidative stress, glutamate, and neurodegenerative disorders;Coyle;Science,1993

2. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor;Mothet;Proc Natl Acad Sci U S A,2000

3. Endogenous d-serine is involved in induction of neuronal death by N-methyl-d-aspartate and simulated ischemia in rat cerebrocortical slices;Katsuki;J Pharmacol Exp Ther,2004

4. Glycine site antagonists and partial agonists inhibit N-methyl-d-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells;Viu;J Pharmacol Exp Ther,1998

5. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety;Jessa;Eur Neuropsychopharmacol,1996

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of novel triazole-urea hybrids and their antiproliferative activity against pancreatic cancer through suppression of eEF2K and induction of apoptosis;Journal of Molecular Structure;2024-09

2. Glutamate secretion by embryonic stem cells as an autocrine signal to promote proliferation;Scientific Reports;2023-11-04

3. Tideglusib Ameliorates Ischemia/Reperfusion Damage by Inhibiting GSK-3β and Apoptosis in Rat Model of Ischemic Stroke;Journal of Stroke and Cerebrovascular Diseases;2022-04

4. Design, Synthesis, and Biological Evaluation of Novel Tomentosin Derivatives in NMDA-Induced Excitotoxicity;Pharmaceuticals;2022-03-30

5. Therapeutic targeting of glycogen synthase kinase-3: Strategy to address neurodegenerative diseases;Protein Kinase Inhibitors;2022